Patent ID: 6428816
Filing Date: 2002-08-06
Classification: A23L,A61K,Y10S

Abstract:
A method of inhibiting carcinogen-mediated conversion of melanocyte cells to melanomas, comprising the step of administering to the cells an anti-tumorigenic composition comprising:0.1 to 10% by weight of a water insoluble carotenoid; and 90 to 99.9% by weight of a non-toxic carrier medium including a suspending agent selected from the group consisting of fatty acids, triglyceride lipids, non-saponifiable lipids, and combinations thereof; an emulsifier selected from the group consisting of a Tween polysorbate glycerol fatty acid esters and acetylated esters of fatty acids; and a water soluble dispersing agent which is a sugar or a polyol.